Oryzon Genomics S.A. (BME:ORY)
3.140
-0.080 (-2.48%)
At close: Feb 27, 2026
Oryzon Genomics Employees
Oryzon Genomics had 47 employees as of June 30, 2025. The number of employees did not change since the number was reported on December 31, 2024.
Employees
47
Change
n/a
Growth
n/a
Revenue / Employee
€156,570
Profits / Employee
€58,639
Market Cap
247.60M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Grifols | 23,800 |
| Laboratorios Farmaceuticos Rovi | 2,188 |
| Almirall | 2,084 |
| Faes Farma | 1,894 |
| Pharma Mar | 500 |
| Clínica Baviera | 1,847 |
| Prim, S.A. | 902 |
| Atrys Health | 2,016 |
Oryzon Genomics News
- 5 days ago - ORYZON Receives European Medicines Agency Approval to Initiate a Phase II Study of iadademstat in Essential Thrombocythemia - Benzinga